Dilmapimod
CAS No. 444606-18-2
Dilmapimod ( SB-681323; GW 681323 )
Catalog No. M24403 CAS No. 444606-18-2
Dilmapimod is a potent inhibitor of p38 MAPK ,it potentially suppresses inflammation in chronic obstructive pulmonary disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 35 | In Stock |
|
10MG | 58 | In Stock |
|
25MG | 110 | In Stock |
|
50MG | 178 | In Stock |
|
100MG | 332 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDilmapimod
-
NoteResearch use only, not for human use.
-
Brief DescriptionDilmapimod is a potent inhibitor of p38 MAPK ,it potentially suppresses inflammation in chronic obstructive pulmonary disease.
-
DescriptionDilmapimod is a potent inhibitor of p38 MAPK ,it potentially suppresses inflammation in chronic obstructive pulmonary disease.
-
SynonymsSB-681323; GW 681323
-
PathwayAutophagy
-
TargetAutophagy
-
RecptorAutophagy;p38 MAPK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number444606-18-2
-
Formula Weight456.4
-
Molecular FormulaC23H19F3N4O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (273.87 mM; Need ultrasonic)
-
SMILESCc(cc(cc1)F)c1-c1c(C=CC(N2c(c(F)ccc3)c3F)=O)c2nc(NC(CO)CO)n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Singh D, et al. A randomized, placebo-controlled study of the effects of the p38 MAPK inhibitor SB-681323 on blood biomarkers of inflammation in COPD patients. J Clin Pharmacol. 2010 Jan;50(1):94-100.
molnova catalog
related products
-
Succinylsulfathiazol...
Succinylsulfathiazole is a sulfonamide, it is an ultra long acting drug.
-
Sulfadoxine
Sulfadoxine(Sulphadoxine) is a long acting sulfonamide that is used, usually in combination with other drugs, for respiratory, urinary tract and malarial infections.
-
Glycycoumarin
Glycycoumarin is an estrogen agonist, it shows moderate inhibitory effects against CYP1A2 and CYP2B6.